Your browser doesn't support javascript.
loading
Chinese medicine for residual symptoms of COVID-19 recovered patients (long COVID)-A double-blind, randomized, and placebo-controlled clinical trial protocol.
Sum, Chi Him; Ching, Jessica Yuet Ling; Song, Tianhe; Cheong, Pui Kuan; Lo, Cho Wing; Lai, Mei Kwan; Chia, Chon Pin; Chan, Kam Leung; Mak, Wing Yan; Leung, Ka Chun; Leung, Sin Bond; Zhang, Hongwei; Lin, Zhixiu.
Affiliation
  • Sum CH; Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Ching JYL; Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Song T; Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Cheong PK; Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Lo CW; Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Lai MK; Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Chia CP; Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Chan KL; Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Mak WY; Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Leung KC; School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Leung SB; Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Zhang H; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Lin Z; Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Front Med (Lausanne) ; 9: 990639, 2022.
Article in En | MEDLINE | ID: mdl-36687403
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Language: En Journal: Front Med (Lausanne) Year: 2022 Document type: Article Affiliation country: China Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Language: En Journal: Front Med (Lausanne) Year: 2022 Document type: Article Affiliation country: China Country of publication: Suiza